Urbach and colleagues showed that FMR1 locus in induced pluripotent stem (iPS) cells derived from FXS individuals is hypermethylated, thus suggesting that its methylation, once established, is stable and not revertible through reprogramming techniques [13]. The gene discussed is FMR1; the disease is fragile X syndrome.